APA (7th ed.) Citation

Schmalzing, M., Froehlich, M., Strunz, P. P., Guggenberger, K. V., Gadeholt, O., Werner, R. A., . . . Gernert, M. (2026). Calprotectin and serum amyloid A for disease activity assessment in giant cell arteritis and polymyalgia rheumatica: Results from a prospective single-centre cohort study. Rheumatology International, 46(3), 1. https://doi.org/10.1007/s00296-026-06081-9

Chicago Style (17th ed.) Citation

Schmalzing, Marc, et al. "Calprotectin and Serum Amyloid A for Disease Activity Assessment in Giant Cell Arteritis and Polymyalgia Rheumatica: Results from a Prospective Single-centre Cohort Study." Rheumatology International 46, no. 3 (2026): 1. https://doi.org/10.1007/s00296-026-06081-9.

MLA (9th ed.) Citation

Schmalzing, Marc, et al. "Calprotectin and Serum Amyloid A for Disease Activity Assessment in Giant Cell Arteritis and Polymyalgia Rheumatica: Results from a Prospective Single-centre Cohort Study." Rheumatology International, vol. 46, no. 3, 2026, p. 1, https://doi.org/10.1007/s00296-026-06081-9.